371 related articles for article (PubMed ID: 28406723)
1. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S
J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723
[TBL] [Abstract][Full Text] [Related]
2. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
Masugi Y; Nishihara R; Yang J; Mima K; da Silva A; Shi Y; Inamura K; Cao Y; Song M; Nowak JA; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig S; Fuchs CS; Qian ZR; Ogino S
Gut; 2017 Aug; 66(8):1463-1473. PubMed ID: 27196573
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
[TBL] [Abstract][Full Text] [Related]
4. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
[TBL] [Abstract][Full Text] [Related]
5. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor
Hamada T; Soong TR; Masugi Y; Kosumi K; Nowak JA; da Silva A; Mu XJ; Twombly TS; Koh H; Yang J; Song M; Liu L; Gu M; Shi Y; Nosho K; Morikawa T; Inamura K; Shukla SA; Wu CJ; Garraway LA; Zhang X; Wu K; Meyerhardt JA; Chan AT; Glickman JN; Rodig SJ; Freeman GJ; Fuchs CS; Nishihara R; Giannakis M; Ogino S
Oncoimmunology; 2018; 7(7):e1442999. PubMed ID: 29900052
[TBL] [Abstract][Full Text] [Related]
6. Association of
Ugai T; Zhao M; Shimizu T; Akimoto N; Shi S; Takashima Y; Zhong R; Lau MC; Haruki K; Arima K; Fujiyoshi K; Langworthy B; Masugi Y; da Silva A; Nosho K; Baba Y; Song M; Chan AT; Wang M; Meyerhardt JA; Giannakis M; Väyrynen JP; Nowak JA; Ogino S
Oncoimmunology; 2021; 10(1):1956173. PubMed ID: 34377593
[TBL] [Abstract][Full Text] [Related]
7. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
[TBL] [Abstract][Full Text] [Related]
8. Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status.
Ahtiainen M; Wirta EV; Kuopio T; Seppälä T; Rantala J; Mecklin JP; Böhm J
Mod Pathol; 2019 Jun; 32(6):866-883. PubMed ID: 30723299
[TBL] [Abstract][Full Text] [Related]
9. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
Hua X; Phipps AI; Burnett-Hartman AN; Adams SV; Hardikar S; Cohen SA; Kocarnik JM; Ahnen DJ; Lindor NM; Baron JA; Newcomb PA
J Clin Oncol; 2017 Aug; 35(24):2806-2813. PubMed ID: 28617623
[TBL] [Abstract][Full Text] [Related]
10. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
Kosumi K; Hamada T; Zhang S; Liu L; da Silva A; Koh H; Twombly TS; Mima K; Morikawa T; Song M; Nowak JA; Nishihara R; Saltz LB; Niedzwiecki D; Ou FS; Zemla T; Mayer RJ; Baba H; Ng K; Giannakis M; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Meyerhardt JA; Ogino S
Eur J Cancer; 2019 Apr; 111():82-93. PubMed ID: 30826660
[TBL] [Abstract][Full Text] [Related]
11.
Hamada T; Zhang X; Mima K; Bullman S; Sukawa Y; Nowak JA; Kosumi K; Masugi Y; Twombly TS; Cao Y; Song M; Liu L; da Silva A; Shi Y; Gu M; Li W; Koh H; Nosho K; Inamura K; Keum N; Wu K; Meyerhardt JA; Kostic AD; Huttenhower C; Garrett WS; Meyerson M; Giovannucci EL; Chan AT; Fuchs CS; Nishihara R; Giannakis M; Ogino S
Cancer Immunol Res; 2018 Nov; 6(11):1327-1336. PubMed ID: 30228205
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
Hamada T; Liu L; Nowak JA; Mima K; Cao Y; Ng K; Twombly TS; Song M; Jung S; Dou R; Masugi Y; Kosumi K; Shi Y; da Silva A; Gu M; Li W; Keum N; Wu K; Nosho K; Inamura K; Meyerhardt JA; Nevo D; Wang M; Giannakis M; Chan AT; Giovannucci EL; Fuchs CS; Nishihara R; Zhang X; Ogino S
Eur J Cancer; 2018 Nov; 103():98-107. PubMed ID: 30219720
[TBL] [Abstract][Full Text] [Related]
13. Aspirin use and risk of colorectal cancer according to BRAF mutation status.
Nishihara R; Lochhead P; Kuchiba A; Jung S; Yamauchi M; Liao X; Imamura Y; Qian ZR; Morikawa T; Wang M; Spiegelman D; Cho E; Giovannucci E; Fuchs CS; Chan AT; Ogino S
JAMA; 2013 Jun; 309(24):2563-71. PubMed ID: 23800934
[TBL] [Abstract][Full Text] [Related]
14. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II-III colorectal cancer.
Huang CY; Chiang SF; Ke TW; Chen TW; You YS; Chen WT; Chao KSC
Sci Rep; 2018 Oct; 8(1):15658. PubMed ID: 30353144
[TBL] [Abstract][Full Text] [Related]
16. CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer.
Lee SJ; Jun SY; Lee IH; Kang BW; Park SY; Kim HJ; Park JS; Choi GS; Yoon G; Kim JG
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1005-1014. PubMed ID: 29520442
[TBL] [Abstract][Full Text] [Related]
17. Inverse relationship between
Ugai T; Shimizu T; Kawamura H; Ugai S; Takashima Y; Usui G; Väyrynen JP; Okadome K; Haruki K; Akimoto N; Masugi Y; da Silva A; Mima K; Zhang X; Chan AT; Wang M; Garrett WS; Freeman GJ; Meyerhardt JA; Nowak JA; Song M; Giannakis M; Ogino S
Clin Transl Immunology; 2023; 12(8):e1453. PubMed ID: 37538192
[TBL] [Abstract][Full Text] [Related]
18. Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.
Masugi Y; Nishihara R; Hamada T; Song M; da Silva A; Kosumi K; Gu M; Shi Y; Li W; Liu L; Nevo D; Inamura K; Cao Y; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig SJ; Fuchs CS; Qian ZR; Nowak JA; Ogino S
Cancer Immunol Res; 2017 Nov; 5(11):1046-1055. PubMed ID: 29038297
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
[TBL] [Abstract][Full Text] [Related]
20. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.
Morikawa T; Kuchiba A; Yamauchi M; Meyerhardt JA; Shima K; Nosho K; Chan AT; Giovannucci E; Fuchs CS; Ogino S
JAMA; 2011 Apr; 305(16):1685-94. PubMed ID: 21521850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
